Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?

Trial Profile

Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 02 May 2017

At a glance

  • Drugs Tick-borne encephalitis vaccine (Primary)
  • Indications Encephalitis virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 May 2015 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2017, according to to ClinicalTrials.gov record.
    • 19 May 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top